Skip to main content
. 2020 May 28;12(6):491. doi: 10.3390/pharmaceutics12060491

Figure 3.

Figure 3

(a) The percentage distribution of crisaborole following the application of 2% ointment for 4 and 16 h; (b) the percentage distribution of crisaborole as a function of application time; and (c) the distribution of crisaborole in the skin and receptor compartment following application of ointment and 2% solution in ACN for 16 h (from Reference [17]). Average values ± sd. * denotes statistical differences (p < 0.05).